XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 33.34

-2.1%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: fred hayes	12/11/2006 11:27:04 AM
	Read Replies (1) of 17367

From briefing.com: 10:43AM XOMA Limited announces Pre-Clinical and Clinical progress on HCD122 (XOMA) 2.18 +0.05 : Co announces "We are pleased to see continued progress in the clinical program for CLL and MM. We are also very encouraged with the results in preclinical animal models of lymphoma that showed a very favorable profile for HCD122," said Jack Castello, chairman of the board, president, and chief executive officer of XOMA. "We continue to believe this is a very promising drug and expect to expand clinical development into other indications during 2007."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next